Basics Bio-Techne Corp Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products. IPO Date: March 1, 1989 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $9.61B Activated in VL: True Average Daily Range Avg Daily Range: $1.48 | 1.15% Avg Daily Range (30 D): $1.11 | 1.83% Avg Daily Range (90 D): $1.02 | 1.79% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): 1.62M Avg Daily Volume (90 D): 1.87M Trade Size Avg Trade Size (Sh.): 61 Avg Trade Size (Sh.) (30 D): 51 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 7,480 Avg Inst. Trade: $4.83M Avg Inst. Trade (30 D): $4.77M Avg Inst. Trade (90 D): $4.06M Avg Inst. Trade Volume: .29M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $8.67M Avg Closing Trade (30 D): $15.57M Avg Closing Trade (90 D): $16.26M Avg Closing Volume: 402.28K     News Nov 5, 2025 @ 11:30 AM BIO-TECHNE DECLARES DIVIDEND Source: Prnewswire Sep 15, 2025 @ 9:29 PM Mdxhealth Announces Closing of Exosome Diagnostics... Source: Globe Newswire Sep 3, 2025 @ 6:45 PM Bio-Techne Stock Upgraded As Analyst Flags Attract... Source: Vandana Singh Aug 14, 2025 @ 2:00 PM Recombinant Human Hair Keratin Protein Market 2025... Source: Towards Healthcare Aug 6, 2025 @ 10:08 PM Bio-Techne (TECH) Q4 EPS Rises 8.2% Source: Jesterai Financials   TTM Q1 2026 Q4 2025 Basic EPS $.51 $.25 $-.11 Diluted EPS $.49 $.24 $-.11 Revenue $ 1.22B $ 286.56M $ 316.96M Gross Profit $ 795.37M $ 188.11M $ 198.81M Net Income / Loss $ 77.99M $ 38.19M $ -17.68M Operating Income / Loss $ 109.93M $ 47.66M $ -23.86M Cost of Revenue $ 421.37M $ 98.44M $ 118.15M Net Cash Flow $ -48.18M $ -16.01M $ 8.16M PE Ratio 125.88     Splits Nov 30, 2022:   4:1 Nov 10, 2022:   4:1 Dec 04, 2000:   2:1